Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic

Serdar Farhan, Haroon Kamran, Birgit Vogel, Karan Garg, Ajit Rao, Navneet Narula, Glenn Jacobowitz, Arthur Tarricone, Vishal Kapur, Peter Faries, Michael Marin, Jagat Narula, Robert Lookstein, Jeffrey W. Olin, Prakash Krishnan

Research output: Contribution to journalEditorial

3 Scopus citations


New York City was one of the epicenters of the COVID-19 pandemic. The management of peripheral artery disease (PAD) during this time has been a major challenge for health care systems and medical personnel. This document is based on the experiences of experts from various medical fields involved in the treatment of patients with PAD practicing in hospitals across New York City during the outbreak. The recommendations are based on certain aspects including the COVID-19 infection status as well as the clinical PAD presentation of the patient. Our case-based algorithm aims at guiding the treatment of patients with PAD during the pandemic in a safe and efficient way.

Original languageEnglish
JournalClinical and Applied Thrombosis/Hemostasis
StatePublished - 2021


  • COVID-19
  • SARS-CoV2
  • acute limb ischemia
  • critical limb ischemia
  • intermittent claudication
  • peripheral artery disease


Dive into the research topics of 'Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic'. Together they form a unique fingerprint.

Cite this